For patients
More choice and the potential to preserve the natural lens.
Reimagining
the future of
cataract care.
Preserving vision.
Preserving the natural lens.
Advancing a non-invasive approach to cataract care, with the ambition to preserve the natural lens.
Explore the challengeThe challenge
Cataract develops gradually.
Treatment does not.
A gap in the treatment journey
Cataract can affect vision long before surgery becomes the right choice.Explore the challengeShow less
Glare, reduced contrast and difficulty driving at night can begin to change daily life. Yet therapeutic options before surgery remain limited.
When intervention is needed, the standard approach is to remove the natural lens and replace it with an artificial one. Surgery is effective for many patients, but it is invasive and irreversible, with associated risks, costs and recovery.
A changing view
over time.
Cataract can change more than sharpness. Contrast, glare and the way light scatters can change too.
Clear vision
Sharp detail. Natural contrast.
Early visual changes
Softening detail. Growing haze.
More pronounced changes
Blurred detail. Scattered light.
Across these visual changes, therapeutic options before surgery remain limited.
Before surgeryLimited therapeutic options
SurgeryNatural lens replacement
We believe patients and physicians
should have another option.
Our vision
More options.
Earlier in the journey.
Our ambition is to make earlier intervention possible while preserving the natural lens.
We aim to expand treatment choice before lens replacement becomes necessary, with the potential to delay surgery and, for some patients, offer an alternative.
For physicians
A new therapeutic option for a broader range of patients.
For healthcare systems
The potential for a more accessible and efficient treatment pathway.
For industry partners
The opportunity to help shape a new category in cataract care.
Our approach
Science focused on
the natural lens.
We are developing a therapeutic approach designed to preserve or restore the natural lens’s transparency.
Our work brings together four complementary disciplines:
OphthalmologyLens biologyBiophysicsEngineering
The opportunity
An established market.
A much larger patient journey.
5M+
Cataract procedures
annually in the U.S.
~33M
Cataract procedures
annually worldwide
Tens of
millions
millions
Americans living
with cataract
Today, therapeutic intervention is still concentrated largely around surgery.
Help shape a new
treatment category.
Explore a collaboration Our team
Science. Medicine.
Technology. Execution.
A multidisciplinary team translating ambitious science into a meaningful new option for cataract patients.
Ido Goldberg
Founder & Chief Executive Officer
Entrepreneur in ophthalmic medical startups. MSc. Biotech & Business.
Prof. Refael Minnes
Founder & Chief Scientific Officer
Head of Bio-Electro-Magnetism Lab, Ariel University
Prof. Michael Mimouni, MD
Chief Medical Officer
Cornea specialist and associate professor. Director of the Cornea Unit at Rambam Hospital
Dr. Eyal Magory
Chief Technology Officer
PhD in Electrical and Electronics Engineering
What comes next
Expanding what’s
possible in
cataract care.
Join us in shaping the future of cataract care.
We invite research collaborations, strategic partnerships and investment conversations to help advance a new therapeutic option.